In recent trading session, NLS Pharmaceutics Ltd (NASDAQ:NLSP) saw 51.83 million shares changing hands at last check today with its beta currently measuring -0.40. Company’s recent per share price level of $2.74 trading at $0.76 or 38.38% at last check today assigns it a market valuation of $6.78M. That most recent trading price of NLSP’s stock is at a discount of -659.12% from its 52-week high price of $20.80 and is indicating a premium of 37.59% from its 52-week low price of $1.71. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.76 million shares which gives us an average trading volume of 1.18 million if we extend that period to 3-months.

For NLS Pharmaceutics Ltd (NLSP), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

NLS Pharmaceutics Ltd (NASDAQ:NLSP) trade information

Upright in the green today for gaining 38.38%, in the last five days NLSP remained trading in the green while hitting it’s week-highest on Friday, 01/31/25 when the stock touched $2.74 price level, adding 18.69% to its value on the day. NLS Pharmaceutics Ltd’s shares saw a change of 29.85% in year-to-date performance and have moved 53.93% in past 5-day. NLS Pharmaceutics Ltd (NASDAQ:NLSP) showed a performance of 0.73% in past 30-days. Number of shares sold short was 85784.0 shares which calculate 0.04 days to cover the short interests.

NLS Pharmaceutics Ltd (NASDAQ:NLSP)’s Major holders

BVF INC/IL is the top institutional holder at NLSP for having 5.75 million shares of worth $1.25 million. And as of 2024-06-30, it was holding 15.0543 of the company’s outstanding shares.

The second largest institutional holder is ARMISTICE CAPITAL, LLC, which was holding about 2.31 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.0535 of outstanding shares, having a total worth of $0.5 million.